YD Bio Ltd (YDES)

YD Bio Ltd (YDES) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $477M; returns 1 day +16.7%, 1 week -16.4%.

YD Bio Ltd (YDES) is a Taiwan-based biopharmaceutical company focused on advancing clinical trials, new drug development, cancer prevention diagnostics, and stem cell and exosome therapies. The company aims to transform the treatment of diseases with high unmet medical needs through scientific innovation and precision medicine.

Groups YDES belongs to

• Biotechnology
• Biopharmaceutical
• Healthcare
• Precision Medicine
• Clinical Stage Biotech
• Oncology
• Early Cancer Detection
• Ophthalmology
• Health Diagnostics and Imaging
• Breast Cancer Treatment
• Pancreatic Cancer
• Gastroenterology

YDES financial model: income statement, cash flow and balance sheet